Artificial pancreas: algorithm in Diabetes Mellitus type 1
DOI:
https://doi.org/10.47196/diab.v53i2Sup.225Keywords:
pancreas, diabetesAbstract
Advances made in the area of clinical research in the use of the artificial pancreas for the treatment of type 1 diabetes mellitus (DM1), as well as its clinical use and future applications in DM2.
References
Kovatchev BP, Renard E, Cobelli C, Zisser HC, Keith-Hynes P, Anderson SM, Brown SA, Cherñavvsky DR, et. al. Feasibility of outpatient fully integrated closed-loop control: first studies of wearable artificial pancreas. Diabetes Care 2013 Jul; 36(7):1851-8. PMCID: PMC3687268.
Cherñavvsky DR, DeBoer MD, et al. Use of an artificial pancreas among adolescents for a missed snack bolus and an underestimated meal bolus. Pediatr Diabetes 2016 Feb; 17(1):28-35.
Ly TT, Buckingham BA, DeSalvo DJ, Shanmugham S, Satin-Smith M, DeBoer MD, Oliveri MC, Schertz E, Breton MD, Cherñavvsky DR. Day and night closed-loop control using the unified safety system in adolescents with type 1 diabetes at camp. Diabetes Care 2016 Jun 6. PMID: 27271182.
Forlenza GP, Ekhlaspour L, Breton M, Maahs DM, Wadwa RP, DeBoer M, Messer LH, Town M, Pinnata J, Kruse G, Buckingham BA, Cherñavvsky DR. Successful at-home use of the tandem control-IQ artificial pancreas system in young children during a randomized controlled trial. Diabetes Technol & Ther 2019 Mar 19.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Dirección Nacional de Derecho de Autor, Exp. N° 5.333.129. Instituto Nacional de la Propiedad Industrial, Marca «Revista de la Sociedad Argentina de Diabetes - Asociación Civil» N° de concesión 2.605.405 y N° de disposición 1.404/13.
La Revista de la SAD está licenciada bajo Licencia Creative Commons Atribución – No Comercial – Sin Obra Derivada 4.0 Internacional.
Por otra parte, la Revista SAD permite que los autores mantengan los derechos de autor sin restricciones.
